DAWN
Day One Biopharmaceuticals
Stock NASDAQ – Stock Market Prices, News & Analysis
Day One Biopharmaceuticals Inc is committed to developing innovative treatments for pediatric cancers and other serious illnesses.
Day One Biopharmaceuticals
DAWN
Day One Biopharmaceuticals Inc is committed to developing innovative treatments for pediatric cancers and other serious illnesses.
Price history of Day One Biopharmaceuticals
Price history of Day One Biopharmaceuticals
Performance & Momentum
DAWN Jumps 66% After Servier Acquisition Deal
Day One Biopharmaceuticals (DAWN) surged over 65% on March 6, 2026, following the announcement of a definitive agreement for its acquisition by the French pharmaceutical group Servier, valuing the deal at approximately $2.5 billion. The all-cash transaction at $21.50 per share fully justifies the strong bullish reaction in the stock price. The market appears to endorse the premium offered and the strategic validation of DAWN's potential by a leading industry player.
Strategic Analysis
Day One Biopharmaceuticals • 2026
Day One Biopharmaceuticals specializes in the development of innovative treatments for pediatric cancers, positioning its model around targeted medical research in oncology. This rare niche in the healthcare sector provides strong differentiation, focusing on pathologies with high medical and social value.
Strengths
- Focus on unmet medical needs in pediatric oncology
- Expertise in developing innovative therapies with high potential impact
- Positioning in a market segment with high barriers to entry promoting a competitive advantage
Weaknesses
- Long-term stock performance marked by significant volatility
- Lack of recent catalysts or major visible news to reignite momentum
Momentum
After a recent strong progression, the momentum remains positive but shows signs of stabilization, indicating a consolidation phase. The absence of specific news to stimulate valuation suggests a need to remain cautious regarding entry timing, betting on the prospect of future clinical successes for sustainable recovery.
Similar stocks to Day One Biopharmaceuticals
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
